When did Cardio Diagnostics (CDIO) last report earnings?

Cardio Diagnostics last reported on Aug 12, 2024, covering fiscal Q2 2024.

Did CDIO beat earnings estimates?

Cardio Diagnostics reported EPS of −$1.80 for Q2 2024, in line with the −$1.80 consensus estimate.

How much revenue did CDIO report last quarter?

Cardio Diagnostics reported $8,000.00 in revenue for Q2 2024, against a consensus estimate of $8,000.00.

Cardio Diagnostics (CDIO) earnings history

Most recent quarter

Fiscal period: Q2 2024
Period end: Jun 30, 2024
EPS actual: −$1.80
EPS estimate: −$1.80
EPS surprise: +0.00%
Revenue surprise: +0.00%
Revenue: $8,000.00
Revenue estimate: $8,000.00
Reported: Aug 12, 2024
SEC filing: View filing

Earnings history

Period	Reported	EPS estimate	EPS actual	Surprise	Revenue	Filing
Q2 2024	Aug 12, 2024	−$1.80	−$1.80	+0.00%	$8,000.00	SEC
Q4 2023	Apr 1, 2024	−$4.05	−$2.10	+48.15%	$2,655.00	SEC
Q3 2023	Nov 13, 2023	−$8.25	−$4.80	+41.82%	$10,030.00	SEC

Quarterly revenue

Q3 2023

$10,030.00

Q4 2023

$2,655.00

Q2 2024

$8,000.00

Frequently asked questions

When did Cardio Diagnostics (CDIO) last report earnings?
Cardio Diagnostics last reported on Aug 12, 2024, covering fiscal Q2 2024.
Did CDIO beat earnings estimates?
Cardio Diagnostics reported EPS of −$1.80 for Q2 2024, in line with the −$1.80 consensus estimate.
How much revenue did CDIO report last quarter?
Cardio Diagnostics reported $8,000.00 in revenue for Q2 2024, against a consensus estimate of $8,000.00.

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by